Both in Pharmaceuticals
Ovid Therapeutics vs Climb Bio
Over the past year OVID returned +106.0% and CLYM returned +396.3%; their daily moves had a correlation of 0.25.
OVID +106.0% CLYM +396.3%Growth of $1, one year, split-adjusted
| Metric | OVID | CLYM |
|---|---|---|
| Price | $2.74 | $9.33 |
| Market cap | $535.1M | $535.9M |
| Today | +14.17% | −4.31% |
| 1 month | +15.6% | −12.6% |
| 6 months | −1.4% | −23.6% |
| Year to date | +68.1% | +133.3% |
| 1 year | +98.6% | +366.5% |
| Revenue growth (YoY) | −88.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −2047.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 338.0× | — |
| Net cash | $117.2M | $183.1M |
| Dividend yield | — | — |
| Volatility (60d) | 64.9% | 80.8% |
| Short % of float | 10.2% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).